Correlation Between Kiromic Biopharma and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Indaptus Therapeutics, you can compare the effects of market volatilities on Kiromic Biopharma and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Indaptus Therapeutics.
Diversification Opportunities for Kiromic Biopharma and Indaptus Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kiromic and Indaptus is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Indaptus Therapeutics
If you would invest 85.00 in Indaptus Therapeutics on November 3, 2024 and sell it today you would earn a total of 6.00 from holding Indaptus Therapeutics or generate 7.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Kiromic Biopharma vs. Indaptus Therapeutics
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Indaptus Therapeutics |
Kiromic Biopharma and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Indaptus Therapeutics
The main advantage of trading using opposite Kiromic Biopharma and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |